Finally, there were significant increases in PGE2-mediated plasma chemokines, MCP-1, MIP-1a, and MIP-1b, in patients with AD/ACLF, with an intermediate phenotype in OPDs (Fig. 4E–G). This evidence concerns the gene CCL2 and Alzheimer disease.